1.Budget impact analysis of apixaban versus other NOACs for the prevention of stroke in Italian atrial fibrillation patients

作　　者：Lorenzo Pradelli ;Mario Calandriello ;Roberto Di Virgilio 等

出　　处：Farmeconomia. Health economics and therapeutic pathways. 2014 ;15(1S):5-14.doi:10.7175/fe.v15i1s.973

出版社：SEEd

文章 ID：100545251

文章详细
2.The economic impact associated with cerebrovascular events related to non-valvular atrial fibrillation (NVAF) in Italy: the role of apixaban

作　　者：Lorenzo Pradelli ;Mario Calandriello ;Roberto Di Virgilio 等

出　　处：Farmeconomia. Health economics and therapeutic pathways. 2014 ;15(1S):3-4.doi:10.7175/fe.v15i1s.972

出版社：SEEd

文章 ID：100545296

文章详细
3.Cost‑effectiveness analysis of apixaban versus other NOACs for the prevention of stroke in Italian atrial fibrillation patients

作　　者：Lorenzo Pradelli ;Mario Calandriello ;Roberto Di Virgilio 等

出　　处：Farmeconomia. Health economics and therapeutic pathways. 2014 ;15(4):101-112.doi:10.7175/fe.v15i4.971

出版社：SEEd

文章 ID：100545352

文章详细
4.Comparative pharmacoeconomic assessment of apixaban vs. standard of care for the prevention of stroke in Italian atrial fibrillation patients

作　　者：Lorenzo Pradelli ;Mario Calandriello ;Roberto Di Virgilio 等

出　　处：Farmeconomia. Health economics and therapeutic pathways. 2014 ;15(1S):15-26.doi:10.7175/fe.v15i1s.974

出版社：SEEd

文章 ID：100545362

文章详细
5.Budget impact analysis of apixaban to treat and prevent venous thromboembolism in Italy

作　　者：Marco Bellone ;Roberto Di Virgilio ;Paolo Di Rienzo

出　　处：Farmeconomia. Health economics and therapeutic pathways. 2016 ;17(3).doi:10.7175/fe.v17i3.1280

出版社：SEEd

文章 ID：193153302

文章详细全文下载

	有全文链接	4篇
	有本地全文	1篇

	Marco Bellone	5篇
	Roberto Di Virgilio	5篇
	Lorenzo Pradelli	4篇
	Marco Tubaro	4篇
	Mario Calandriello	4篇

全文

出版年度

作者

来源期刊

学科主题

语种

国别/地区

检索条件:"( ( 高级检索(( ((AU:(("Roberto Di Virgilio")))) )) ) )"

	2016	1篇
	2014	4篇